Are urology residents adequately exposed to conservative therapies for managing small renal masses?

Journal of Endourology

Volumn 25, Issue 1, 2011, Pages 129-133

  Elliott, Vanessa L ^a   Smith, Paul H ^a   Raman, Jay D ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ARTICLE; COMORBIDITY; CONSERVATIVE TREATMENT; DISEASE SURVEILLANCE; HUMAN; JOB EXPERIENCE; KIDNEY TUMOR; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL SOCIETY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; QUESTIONNAIRE; RESIDENT; SMALL RENAL MASS; UROLOGY;

ABLATION TECHNIQUES; AGED; HUMANS; INTERNSHIP AND RESIDENCY; KIDNEY NEOPLASMS; MIDDLE AGED; QUESTIONNAIRES; UROLOGY;

EID: 79951600480     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2010.0450     Document Type: Article

References (21)

1. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA 1999;281:1628-1631. (Pubitemid 29211773)
2. Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: An analysis of surveillance, epidemiology and end results program data. J Urol 2002;167:57-60. (Pubitemid 34024497)
3. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: A need to reassess treatment effect. J Natl Cancer Inst 2006;98:1331-1334. (Pubitemid 44530728)
4. Rendon RA, Stanietzky N, Panzarella T, Robinette M, Klotz LH, Thurston W, Jewett MA. The natural history of small renal masses. J Urol 2000;164:1143-1147.
5. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-Year followup. J Urol 2000;163:442-445. (Pubitemid 30060489)
6. Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, Scardino PT, Russo P. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: A retrospective cohort study. Lancet Oncol 2006;7:735-740. (Pubitemid 44283660)
7. Gill IS, Kavoussi LR, Lane BR, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007;178:41-46. (Pubitemid 46898481)
8. Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DY, Uzzo RG. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer 2009;115:2844-2852.
9. Jewett MA, Zuniga A. Renal tumor natural history: The rationale and role for active surveillance. Urol Clin North Am 2008;35:627-634, vii.
10. Aron M, Kamoi K, Remer E, Berger A, Desai M, Gill I. Laparoscopic renal cryoablation: 8-Year, single surgeon outcomes. J Urol 2010;183:889-895.
11. Salas N, Ramanathan R, Dummett S, Leveillee RJ. Results of radiofrequency kidney tumor ablation: Renal function preservation and oncologic efficacy. World J Urol 2010;28:583-591.
12. Duchene DA, Moinzadeh A, Gill IS, Clayman RV, Winfield HN. Survey of residency training in laparoscopic and robotic surgery. J Urol 2006;176:2158-2166; discussion 2167.
13. James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet 2010;375: 1296-1309.
14. Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors-is there a difference in mortality and cardiovascular outcomes? JUrol 2009;181:55-61; discussion 61-62.
15. Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: Indications, techniques and outcomes. J Urol 2001; 166:6-18. (Pubitemid 32565331)
16. Tracy C, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes following radiofrequency ablation (RFA): Experience from treating 243 small renal masses over 7.5 years. J Urol 2010;183:e573.
17. Aron M, Kamoi K, Remer E, Berger A, Brandina R, Desai M, Gill IS. Laparoscopic renal cryoablation with 8-year median follow-up: Single surgeon experience. J Urol 2010;183: e382.
18. Bandi G, Hedican SP, Nakada SY. Current practice patterns in the use of ablation technology for the management of small renal masses at academic centers in the United States. Urology 2008;71:113-117. (Pubitemid 351173257)
19. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Five-year survival after surgical treatment for kidney cancer: A population-based competing risk analysis. Cancer 2007; 109:1763-1768. (Pubitemid 46668538)
20. Long L, Park S. Differences in patterns of care: Reablation and nephrectomy rates after needle ablative therapy for renal masses stratified by medical specialty. J Endourol 2009; 23:421-426.
21. Kunkle DA, Uzzo RG. Significant differences exist in reporting for ablation of renal masses: A comparison of studies published in urology and radiology literature. J Urol 2008; 179:143-144.